Pseudo-glutarylcarnitinaemia in medium-chain acyl-CoA dehydrogenase deficiency detected by tandem mass spectrometry newborn screening

[1]  V. Wiley,et al.  Application of tandem mass spectrometry to biochemical genetics and newborn screening. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[2]  B. Wilcken,et al.  Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies , 2001, Archives of disease in childhood. Fetal and neonatal edition.

[3]  I Knudsen,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. , 2001, American journal of human genetics.

[4]  B. Wilcken,et al.  Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[5]  D. Chace,et al.  Automated Tandem Mass Spectrometry for Mass Newborn Screening for Disorders in Fatty Acid, Organic Acid, and Amino Acid Metabolism , 1999, Journal of child neurology.

[6]  M. Vincent,et al.  Identification of new medium-chain acylcarnitines present in urine of a patient with medium-chain acyl-CoA dehydrogenase deficiency , 1999, Journal of Inherited Metabolic Disease.

[7]  M. Morris,et al.  Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry , 1998, Archives of disease in childhood.

[8]  P. Ozand.  Diagnosis of inborn errors of metabolism by tandem mass spectrometry. , 1998, Annals of Saudi medicine.

[9]  M. Vincent,et al.  Identification of new medium-chain acylcarnitines present in normal human urine. , 1997, Analytical biochemistry.

[10]  M. Jacob,et al.  Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. , 1997, Clinical chemistry.

[11]  J. Pitt,et al.  Novel glycine conjugates in medium-chain acyl-CoA dehydrogenase deficiency , 1993, Journal of Inherited Metabolic Disease.

[12]  D. Kerr,et al.  Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. , 1990, Journal of lipid research.

[13]  J. O’Shea,et al.  Stable isotope dilution analysis of n-hexanoylglycine, 3-phenylpropionylglycine and suberylglycine in human urine using chemical ionization gas chromatography/mass spectrometry selected ion monitoring. , 1989, Biomedical & environmental mass spectrometry.

[14]  D. Chace,et al.  The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. , 2002, Annual review of genomics and human genetics.

[15]  O. Linderkamp,et al.  Postnatal Changes in Neonatal Acylcarnitine Profile , 2001, Pediatric Research.

[16]  O. Mamer,et al.  Episodic hypoglycemia with psi-hydroxy fatty acid excretion. , 1983, Pediatric research.